Antimicrobial hydrolyzed collagen compositions and methods of using the same
A hydrolyzed collagen composition with biguanides, vicinal diols, and chelating agents addresses the lack of antimicrobial efficacy in wound care, achieving significant microbial reduction and promoting tissue healing.
WO2026080745A1 Publication Date: 2026-04-16ROCHAL TECHNOLOGIES LLC
5 Cites 0 Cited by
Patent Information
- Application Number
- PCT/US2025/050322
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-10
- Filing Date
- 2025-10-09
- Publication Date
- 2026-04-16
AI Technical Summary
Technical Problem
Existing wound care solutions lack effective antimicrobial properties while maintaining biocompatibility, leading to issues with infection and impaired tissue healing.
Method used
A hydrolyzed collagen composition incorporating at least one biguanide, one hydrophobic vicinal diol, and one chelating agent, which provides at least a 2-log reduction of planktonic microbes and enhances tissue healing by reducing pathogens without cytotoxicity.
Benefits of technology
The composition effectively reduces and eliminates a wide range of microbes and pathogens on wounds, tissues, and devices, promoting tissue healing and maintaining biocompatibility.
✦ Generated by Eureka AI based on patent content.
Abstract
A composition is provided that includes hydrolyzed collagen, at least one biguanide, at least one vicinal diol, and at least one chelating agent. The composition exhibits at least 2-log reduction of planktonic microbes within 24 hours. Methods of using the composition are also provided.
Need to check novelty before this filing date? Find Prior Art